후보 약물군 | 약물종류 |
산분비억제제 | - PPI: omeprazole, lansoprazole, rabeprazole, pantoprazole, esomeprazole, ilaprazole
- H2RA: cimetidine, ranitidine, famotidine, nizatidine, roxatidine, lafutidine
- P-CAB (Potassium-competitive acid blocker)(reversible PPI): revaprazan, vonoprazan(New), tegoprazan(New)
|
제산제 | - Aluminum compound: Aluminum Phosphate, Almagate, Aluminum hydroxide, Aluminum Mg silicate
- Mg compound: MgO, Diomagnite, hydrotalcite
- Ca compound: CaCO3
|
방어인자증강제(점막보호제) | - Sucralfate, Colloidal bismuth subcitrate (De-Nol), Bismuth subsalicylate(BSS, Pepto-Bistol)
|
방어인자증강제(기타 약물) | - 프로스타글란딘 E 유사체(Misoprostol), Sulglycotid, Troxipide, Teprenone, Rebamipide
|
위장관운동촉진제(prokinetics) | - Dopamine receptor antagonists
- Central D2 receptor antagonist: Levosulpiride, metoclopramide
- peripheral D2 receptor anagonist: domperidone, itopride
- Serotonergic agents
- 5-HT4 receptor agonist - 1세대: cisapride, Tegaserod, Renzapride - 2세대: mosapride
- 5-HT1 receptor agonist: Sumatriptan, buspirone
- Motilin/ghrelin receptor agonist
- Motilin receptor agonist: erythromycin, motilides
- Ghrelin receptor agonist
- Cholecystokinin-1(CCK-1) receptor antagonist: Loxiglumide, Dexloxiglmide
|
위저부 이완제 | - 5-HT1A 수용체 작용제: Sumatriptan, buspirone, tandospirone
- 5-HT4 receptor agonist: cisapride, tegaserod
- Acotiamide(New)
|
내장 과감각 억제제 | - 5-HT3 수용체길항제: granisetron
- Cholecystokinin-1(CCK-1) receptor antagonist: Loxiglumide, Dexloxiglmide
- 소마토스타틴 유사제: octreotide
- κ-오피오이드 수용체 작용제: fedotozine, asimadoline
- 뉴로키닌 수용체 길항제
|
정신과 약제(Psychoactive medications) | - TCA: amitriptyline
- SSRIs: escitalopram
- Serotonin 5-HT1A receptor agonist: Buspirone①
- 기타: Mirtazapine, Benzodiazepine
|
생약 | - 베나치오큐액®, Rikkunshito(New)
|